Ramiro E Gilardino

I lead the access and policy strategies that enable innovative medicines to reach patients across Europe, Latin America, and global markets. With 16+ years at the intersection of HTA, market access, and health policy, I have led access strategy in some of the most complex regulatory environments in the industry, including EU Joint Clinical Assessment, IRA, and evolving global pricing scrutiny, helping organizations anticipate and navigate change across launch and lifecycle. I focus on oncology, rare disease, and specialty portfolios. I have supported 20+ global product launches and built market access capabilities from the ground up, translating complex policy environments into actionable pricing, reimbursement, and evidence strategies. I bring a combination of clinical training, health economics expertise, and policy fluency, operating at the executive level across industry, consulting, and global institutions. My work includes shaping HTA frameworks and access environments through bo